Aurobindo Pharma

1,255.65
+0.90
(0.07%)
Market Cap (₹ Cr.)
₹72,876
52 Week High
1,592.00
Book Value
₹509
52 Week Low
958.50
PE Ratio
20.17
PB Ratio
2.38
PE for Sector
41.08
PB for Sector
4.17
ROE
10.62 %
ROCE
21.92 %
Dividend Yield
0.36 %
EPS
₹61.22
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
17.55 %
Net Income Growth
64.39 %
Cash Flow Change
2.00 %
ROE
47.91 %
ROCE
46.72 %
EBITDA Margin (Avg.)
35.82 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Revenue
2,045
2,244
2,218
2,404
2,472
2,451
2,445
2,551
2,471
2,200
3,103
2,720
2,361
2,562
3,175
3,385
3,309
3,109
3,255
3,384
3,795
3,547
4,592
3,894
4,382
2,938
2,966
2,754
3,301
1,780
2,004
2,439
2,733
2,504
2,772
3,023
3,017
2,525
2,947
Expenses
1,538
1,618
1,662
1,713
1,843
1,863
1,817
1,887
1,840
1,700
2,035
2,022
1,877
2,162
2,563
2,650
2,546
2,528
2,590
2,695
2,799
2,466
3,341
2,759
3,138
2,483
2,543
2,407
2,455
1,529
1,700
1,941
1,830
1,969
2,124
2,210
2,119
1,961
2,104
EBITDA
507
626
556
690
628
587
628
664
631
500
1,068
698
484
400
611
735
763
581
665
689
996
1,082
1,251
1,134
1,243
455
422
347
846
251
304
498
902
536
648
813
898
564
844
Operating Profit %
24 %
25 %
23 %
27 %
22 %
21 %
23 %
23 %
22 %
20 %
32 %
23 %
18 %
13 %
17 %
16 %
20 %
16 %
18 %
17 %
21 %
26 %
25 %
26 %
24 %
14 %
11 %
8 %
15 %
12 %
12 %
17 %
23 %
17 %
20 %
17 %
26 %
19 %
24 %
Depreciation
63
63
66
67
67
70
71
71
73
83
90
90
92
94
101
109
109
115
118
119
120
121
121
122
124
115
98
101
101
56
61
60
67
60
66
64
65
67
68
Interest
16
20
41
12
16
14
12
10
9
10
12
13
17
24
31
41
35
32
25
21
20
10
6
6
6
5
3
4
5
6
12
25
32
32
37
61
53
51
52
Profit Before Tax
428
543
449
611
545
503
545
582
549
407
966
595
375
282
479
585
619
434
522
549
856
951
1,123
1,006
1,113
335
321
243
740
189
231
413
804
444
546
687
780
446
724
Tax
91
135
108
147
132
112
125
141
93
99
214
150
38
55
73
111
141
82
109
119
185
245
321
268
209
143
122
89
25
77
70
123
161
116
137
137
208
120
188
Net Profit
337
408
341
464
413
391
419
441
456
307
753
444
308
225
381
464
460
331
398
419
718
708
797
736
873
215
198
240
802
122
165
299
645
336
416
624
579
329
538
EPS in ₹
11.55
13.97
5.82
8.00
7.07
6.68
7.16
7.53
7.78
5.25
12.85
7.58
5.26
3.84
6.50
7.91
7.85
5.64
6.80
7.15
12.25
12.07
13.60
12.56
14.89
3.67
3.37
4.09
13.69
2.32
2.81
5.10
11.00
5.74
7.10
10.65
9.88
5.62
9.21

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
10,226
12,566
13,023
15,794
18,141
19,564
23,189
21,601
25,059
25,154
Fixed Assets
2,190
2,568
3,212
3,393
4,150
4,418
4,472
3,586
3,688
2,419
Current Assets
6,368
7,775
6,903
8,981
10,408
11,288
12,336
9,835
9,965
7,239
Capital Work in Progress
227
742
907
1,144
789
815
735
225
239
133
Investments
20
1,183
1,682
1,968
2,339
2,527
5,010
6,584
8,105
13,393
Other Assets
7,789
8,072
7,222
9,289
10,863
11,804
12,972
11,206
13,027
9,209
Total Liabilities
10,226
12,566
13,023
15,794
18,141
19,564
23,189
21,601
25,059
25,154
Current Liabilities
3,946
5,344
4,447
5,754
6,737
6,372
6,757
4,181
6,679
5,245
Non Current Liabilities
920
356
140
57
54
139
508
303
346
186
Total Equity
5,360
6,866
8,436
9,983
11,351
13,053
15,925
17,117
18,034
19,723
Reserve & Surplus
5,330
6,807
8,378
9,924
11,292
12,994
15,866
17,059
17,975
19,664
Share Capital
29
59
59
59
59
59
59
59
59
59

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
1
310
-414
372
-171
-1
316
-335
306
-274
Investing Activities
-624
-1,390
-1,542
-991
-1,301
-948
-2,650
-1,615
-3,230
-152
Operating Activities
590
1,185
2,457
922
530
2,201
2,995
3,727
1,816
1,715
Financing Activities
35
515
-1,329
440
599
-1,255
-28
-2,448
1,720
-1,837

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Promoter
51.94 %
51.83 %
51.83 %
51.83 %
51.83 %
51.83 %
51.83 %
51.83 %
51.83 %
51.83 %
51.83 %
51.83 %
51.83 %
51.80 %
51.82 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
0.00 %
0.00 %
0.00 %
0.00 %
18.02 %
16.73 %
16.59 %
DIIs
10.99 %
12.72 %
13.82 %
15.11 %
15.83 %
15.58 %
16.23 %
14.89 %
15.08 %
15.73 %
17.94 %
20.23 %
23.28 %
24.77 %
25.13 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
8.71 %
8.54 %
9.60 %
8.99 %
8.37 %
8.80 %
8.65 %
9.42 %
8.54 %
7.01 %
6.15 %
5.64 %
5.52 %
5.47 %
5.33 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,799.35 4,33,931.70 38.70 49,887.20 12.06 9,648 27.34 51.02
1,549.05 1,21,755.80 26.38 26,520.70 14.17 4,155 12.95 47.09
2,594.05 1,04,826.50 49.54 10,615.60 19.57 1,942 28.89 52.27
1,221.80 1,01,936.60 19.09 28,905.40 12.36 5,578 -9.47 42.97
984.55 98,062.50 22.93 19,831.50 13.82 3,831 14.57 48.47
2,082.35 94,399.90 35.95 20,141.50 19.94 1,936 73.53 47.09
1,248.90 72,876.10 20.17 29,559.20 17.55 3,169 8.66 35.95
5,641.70 68,065.40 31.30 12,978.40 9.84 1,812 14.16 50.35
375.70 45,064.50 32.35 15,621.20 35.25 1,298 -84.31 68.22
1,556.25 43,670.00 - 12,653.10 6.58 -1,831 675.49 44.51

Corporate Action

Technical Indicators

RSI(14)
Neutral
35.95
ATR(14)
Less Volatile
33.48
STOCH(9,6)
Neutral
40.89
STOCH RSI(14)
Overbought
97.90
MACD(12,26)
Bullish
5.26
ADX(14)
Very Strong Trend
52.35
UO(9)
Bearish
47.01
ROC(12)
Downtrend But Slowing Down
-1.00
WillR(14)
Neutral
-73.02